Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

EBioMedicine

Volumn 13, Issue , 2016, Pages 305-314

  Venner, Colin M ^a   Nankya, Immaculate ^b,c   Kyeyune, Fred ^b   Demers, Korey ^b,c   Kwok, Cynthia ^d   Chen, Pai Lien ^d   Rwambuya, Sandra ^b,c   Munjoma, Marshall ^e   Chipato, Tsungai ^e   Byamugisha, Josaphat ^f   Van Der Pol, Barbara ^g   Mugyenyi, Peter ^b   Salata, Robert A ^c   Morrison, Charles S ^d   Arts, Eric J ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FAMILY HEALTH INTERNATIONAL   (United States)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^f MAKERERE UNIVERSITY   (Uganda)

^g University of Alabama at Birmingham   (United States)

Author keywords

Africa; Disease progression; HIV 1 diversity; Pathogenesis; Subtypes

Indexed keywords

AFRICA; ARTICLE; BEHAVIOR CHANGE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD; VIRUS VIRULENCE; AFRICA SOUTH OF THE SAHARA; CLASSIFICATION; FOLLOW UP; GENETIC VARIATION; GENETICS; GENOTYPE; GEOGRAPHY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; REPRODUCTIVE FITNESS; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

AFRICA SOUTH OF THE SAHARA; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC FITNESS; GENETIC VARIATION; GENOTYPE; GEOGRAPHY; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD; VIRUS REPLICATION;

EID: 85002194781     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.10.014     Document Type: Article

References (44)

1. Abraha, A., Nankya, I.L., Gibson, R., Demers, K., Tebit, D.M., Johnston, E., et al. J. Virol., 2009 March 18.
2. Amornkul, P.N., Karita, E., Kamali, A., Rida, W.N., Sanders, E.J., Lakhi, S., et al. Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS 27:17 (2013 November 13), 2775–2786.
3. Arien, K.K., Abraha, A., Quinones-Mateu, M.E., Kestens, L., Vanham, G., Arts, E.J., The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 79:14 (2005 July), 8979–8990.
4. Arien, K.K., Vanham, G., Arts, E.J., Is HIV-1 evolving to a less virulent form in humans?. Nat. Rev. Microbiol. 5:2 (2007 February), 141–151.
5. Baeten, J.M., Chohan, B., Lavreys, L., Chohan, V., McClelland, R.S., Certain, L., et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 195:8 (2007 April 15), 1177–1180.
6. Ball, S.C., Abraha, A., Collins, K.R., Marozsan, A.J., Baird, H., Quinones-Mateu, M.E., et al. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C 1. J. Virol. 77:2 (2003 January 15), 1021–1038.
7. Bark, C.M., Morrison, C.S., Salata, R.A., Byamugisha, J.K., Katalemwa, N.H., Mugerwa, R.D., et al. Acceptability of treatment of latent tuberculosis infection in newly HIV-infected young women in Uganda. Int J Tuberc Lung Dis 14:12 (2010 December), 1647–1649.
8. Cao, K., Moormann, A.M., Lyke, K.E., Masaberg, C., Sumba, O.P., Doumbo, O.K., et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 63:4 (2004 April), 293–325.
9. Demeulemeester, J., Vets, S., Schrijvers, R., Madlala, P., De, M.M., De, R.J., et al. HIV-1 integrase variants retarget viral integration and are associated with disease progression in a chronic infection cohort. Cell Host Microbe 16:5 (2014 November 12), 651–662.
10. Dudley, D.M., Gao, Y., Nelson, K.N., Henry, K.R., Nankya, I., Gibson, R.M., et al. A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates. BioTechniques 46:6 (2009 May), 458–467.
11. Edgar, R.C., MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:5 (2004), 1792–1797.
12. Gouy, M., Guindon, S., Gascuel, O., SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27:2 (2010 February), 221–224.
13. Kaleebu, P., French, N., Mahe, C., Yirrell, D., Watera, C., Lyagoba, F., et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185:9 (2002 May 1), 1244–1250.
14. Kanki, P.J., Hamel, D.J., Sankale, J.L., Hsieh, C., Thior, I., Barin, F., et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179:1 (1999 January), 68–73.
15. Kijak, G.H., Walsh, A.M., Koehler, R.N., Moqueet, N., Eller, L.A., Eller, M., et al. HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster. Tissue Antigens 73:3 (2009 March), 262–269.
16. King, D.F., Siddiqui, A.A., Buffa, V., Fischetti, L., Gao, Y., Stieh, D., et al. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus. J. Virol. 87:2 (2013 January), 890–899.
17. Kiwanuka, N., Robb, M., Laeyendecker, O., Kigozi, G., Wabwire-Mangen, F., Makumbi, F.E., et al. HIV-1 viral subtype differences in the rate of CD4 + T-cell decline among HIV seroincident antiretroviral naive persons in Rakai District, Uganda. J. Acquir. Immune Defic. Syndr., 11, 2009 December.
18. Kyeyune, F., Nankya, I., Metha, S., Akao, J., Ndashimye, E., Tebit, D.M., et al. Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus A infected Ugandans: a ten year history in Kampala, Uganda. AIDS, 2013 March 18.
19. Lemonovich, T.L., Watkins, R.R., Morrison, C.S., Kwok, C., Chipato, T., Musoke, R., et al. Differences in clinical manifestations of acute and early HIV-1 infection between HIV-1 subtypes in African women. J Int Assoc Provid AIDS Care 14:5 (2015 September), 415–422.
20. Limou, S., Zagury, J.F., Immunogenetics: genome-wide association of non-progressive HIV and viral load control: HLA genes and beyond. Front. Immunol., 4, 2013, 118.
21. Lineberger, J.E., Danzeisen, R., Hazuda, D.J., Simon, A.J., Miller, M.D., Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion. J. Virol. 76:7 (2002 April), 3522–3533.
22. Lobritz, M.A., Lassen, K.G., Arts, E.J., HIV-1 replicative fitness in elite controllers. Curr. Opin. HIV AIDS 6:3 (2011 May), 214–220.
23. Lovvorn, A.E., Patnaik, P., Walker, C.J., Kwok, C., van der Pol, B., Chipato, T., et al. Variations in CD4 cell counts among HIV-uninfected and infected women in Uganda and Zimbabwe. Int. J. STD AIDS 21:5 (2010 May), 342–345.
24. Mann, J.K., Chopera, D., Omarjee, S., Kuang, X.T., Le, A.Q., Anmole, G., et al. Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure. Virology 468–470 (2014 November), 214–225.
25. Marozsan, A.J., Moore, D.M., Lobritz, M.A., Fraundorf, E., Abraha, A., Reeves, J.D., et al. Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry. J. Virol. 79:11 (2005 June), 7121–7134.
26. McLaren, P.J., Carrington, M., The impact of host genetic variation on infection with HIV-1. Nat. Immunol. 16:6 (2015 June), 577–583.
27. McLaren, P.J., Fellay, J., Human genetic variation in HIV disease: beyond genome-wide association studies. Curr. Opin. HIV AIDS 10:2 (2015 March), 110–115.
28. Mellors, J.W., Rinaldo, C.R. Jr., Gupta, P., White, R.M., Todd, J.A., Kingsley, L.A., Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:5265 (1996 May 24), 1167–1170.
29. Montano, M.A., Nixon, C.P., Ndung'u, T., Bussmann, H., Novitsky, V.A., Dickman, D., et al. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J Infect Dis 181:1 (2000 January), 76–81.
30. Morrison, C.S., Richardson, B.A., Mmiro, F., Chipato, T., Celentano, D.D., Luoto, J., et al. Hormonal contraception and the risk of HIV acquisition. AIDS 21:1 (2007 January 2), 85–95.
31. Morrison, C.S., Demers, K., Kwok, C., Bulime, S., Rinaldi, A., Munjoma, M., et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS 24:4 (2010 February 20), 573–582.
32. Morrison, C.S., Chen, P.L., Nankya, I., Rinaldi, A., van der Pol, B., Ma, Y.R., et al. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe. J. Acquir. Immune Defic. Syndr., 24, 2011 February.
33. Munoz, A., Kirby, A.J., He, Y.D., Margolick, J.B., Visscher, B.R., Rinaldo, C.R., et al. Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4 + lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 8:5 (1995 April 15), 496–505.
34. Palm, A.A., Esbjornsson, J., Mansson, F., Kvist, A., Isberg, P.E., Biague, A., et al. Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3. J Infect Dis 209:5 (2014 March 1), 721–728.
35. Paximadis, M., Mathebula, T.Y., Gentle, N.L., Vardas, E., Colvin, M., Gray, C.M., et al. Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population. Hum. Immunol. 73:1 (2012 January), 80–92.
36. Rainwater, S., Devange, S., Sagar, M., Ndinya-Achola, J., Mandaliya, K., Kreiss, J.K., et al. No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate. AIDS Res. Hum. Retrovir. 21:12 (2005 December), 1060–1065.
37. Reed, L.J., Muench, H., A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938), 493–497 Ref Type: Journal (Full).
38. Rubio, A.E., Abraha, A., Carpenter, C.A., Troyer, R.M., Reyes-Rodriguez, A.L., Salomon, H., et al. Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina. PLoS One, 9(4), 2014, e92084.
39. Sharp, P.M., Hahn, B.H., Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med, 1(1), 2011 September, a006841.
40. Tebit, D.M., Arts, E.J., Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect. Dis. 11:1 (2011 January), 45–56.
41. Troyer, R.M., Collins, K.R., Abraha, A., Fraundorf, E., Moore, D.M., Krizan, R.W., et al. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J. Virol. 79:14 (2005 July), 9006–9018.
42. van, O.T., Jeeninga, R.E., Boerlijst, M.C., Pollakis, G.P., Zetterberg, V., Salminen, M., et al. Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J. Virol. 78:7 (2004 April), 3675–3683.
43. Velazquez-Campoy, A., Todd, M.J., Vega, S., Freire, E., Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes. Proc. Natl. Acad. Sci. U. S. A. 98:11 (2001 May 22), 6062–6067.
44. Weber, J., Vazquez, A.C., Winner, D., Gibson, R.M., Rhea, A.M., Rose, J.D., et al. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism. J. Clin. Microbiol. 51:5 (2013 May), 1517–1527.